Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0006-291x(73)90796-1 | DOI Listing |
Chem Biodivers
January 2025
Department of Chemistry, Faculty of Science, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Lantana montevidensis (Spreng.) Briq. is a shrub native to South American countries.
View Article and Find Full Text PDFHeliyon
September 2024
Department of Agricultural Sciences, University of Naples Federico II, 80055, Portici, Naples, Italy.
Hemoglobin
May 2024
Dana-Farber Cancer Institute - Department of Medical Oncology, Boston, MA, USA.
Due to the significant morbidity and mortality of hemoglobinopathies, curative options have long been pursued. The overall goal of gene therapy is to modify a patient's own hematopoietic stem cells to overcome the deleterious effects of the underlying genetic defect by gene addition, gene editing, or gene silencing. Gene addition incorporates genes with superior function than the abnormal gene; gene editing takes advantage of molecular tools such as zinc finger proteins, Transcription Activator-Like Effector Nucleases and Clustered Regularly Interspaced Short Palindromic Repeats coupled with Cas9 proteins (CRISPR-Cas9) which allow for sequence-specific breaks in DNA that disrupt gene function; and gene silencing suppresses gene expression by interference with mRNA transcription/protein translation or epigenetic modification.
View Article and Find Full Text PDFACS Pharmacol Transl Sci
June 2023
Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India.
The use of adjuvant therapy is an attractive approach to manage sickle cell disease (SCD) symptomatically. The present study aimed to investigate the potential of ellagic acid as an adjuvant therapy with hydroxyurea (HU), a key drug for SCD with myelosuppressive toxic effects. A panel of experiments was performed using SCD patient's blood (ex vivo) and transgenic mice model of SCD (in vivo).
View Article and Find Full Text PDFCells
April 2023
Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil.
Background: Sickle cell disease (SCD) is a highly prevalent genetic disease caused by a point mutation in the gene, which can lead to chronic hemolytic anemia and vaso-occlusive events. Patient-derived induced pluripotent stem cells (iPSCs) hold promise for the development of novel predictive methods for screening drugs with anti-sickling activity. In this study, we evaluated and compared the efficiency of 2D and 3D erythroid differentiation protocols using a healthy control and SCD-iPSCs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!